Articles - Immune-Mediated Inflammatory Diseases A specially curated list of peer-reviewed articles discussing the latest knowledge in the treatment and management of Immune-Mediated Inflammatory Diseases. Filter by TopicEffective discussion around residual symptomsInter-relationship between Autoimmune DiseasesPatients on treatment may still suffer from symptomsPatients on treatment with residual symptoms Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required? READ MORE Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities READ MORE A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis READ MORE Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis READ MORE Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A Review READ MORE Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs READ MORE Management of the refractory vitiligo patient: current therapeutic strategies and future options READ MORE Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies READ MORE Inflammation across tissues: can shared cell biology help design smarter trials? READ MORE Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations READ MORE The presentation of anxiety and depression among children and youth diagnosed with hidradenitis suppurativa: A review READ MORE The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe READ MORE Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis READ MORE Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 READ MORE Psoriasis seems often underdiagnosed in patient with axial spondyloarthritis READ MORE Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study READ MORE Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriers READ MORE Understanding Discordant Perceptions of Disease Severity Between Physicians and Patients With Eczema and Psoriasis Using Structural Equation Modeling READ MORE Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies READ MORE ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease READ MORE Comorbidities & burden of disease in atopic dermatitis READ MORE First update of the living European guideline (EuroGuiDerm) on atopic eczema READ MORE The Treat-to-Target Project in Atopic Dermatitis: One Year On READ MORE Is there an optimal sequence of biologic therapies for inflammatory bowel disease? READ MORE Association of atopic dermatitis with autoimmune diseases: A bidirectional and multivariable two-sample mendelian randomization study READ MORE Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies READ MORE Defining the Failure of Medical Therapy for Inflammatory Bowel Disease in the Era of Advanced Therapies: A Systematic Review READ MORE Exploring the perspective of patients with immune-mediated inflammatory diseases and care providers on the use of immunomodulatory drugs in infections: an interview study READ MORE Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe READ MORE Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study READ MORE The Association Between Nonsteroidal Anti-Inflammatory Drug Use and Inflammatory Bowel Disease Exacerbations: A True Association or Residual Bias? READ MORE Comprehensive overview of autoantibody isotype and subclass distribution READ MORE EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update READ MORE Immune-mediated diseases and subsequent risk of alopecia areata in a prospective study of US women READ MORE Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic ArthritisA Bidirectional 2-Sample Mendelian Randomization Study READ MORE A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases READ MORE Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations READ MORE Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations READ MORE Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations READ MORE Management of refractory inflammatory bowel disease READ MORE Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 READ MORE Meta-Analyses on the Effects of Disease-Modifying Antirheumatic Drugs on the Most Relevant Patient-Reported Outcome Domains in Rheumatoid Arthritis READ MORE Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review READ MORE Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence READ MORE Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis READ MORE How Should Pain, Fatigue, and Emotional Wellness Be Incorporated Into Treatment Goals for Optimal Management of Inflammatory Bowel Disease? READ MORE Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management READ MORE Physician’s perspective regarding asthma guided self-management: directives or guidance? READ MORE Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity READ MORE EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations READ MORE EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations READ MORE STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD READ MORE Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement READ MORE IBD considerations in spondyloarthritis READ MORE Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis READ MORE Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs READ MORE Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry READ MORE The association between anxiety and disease activity and quality of life in rheumatoid arthritis: a systematic review and meta-analysis READ MORE The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life READ MORE The current standard of care and the unmet needs for axial spondyloarthritis READ MORE Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder READ MORE The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease READ MORE
